Immunostaining of anti-Bcl-2 antibody in diseased human muscles

Clinical Neurology

Volumn 36, Issue 6, 1996, Pages 735-740

  Ibi, Tohru ^a,b   Sahashi, Ko ^a,b,c   Jing, Ling ^a   Zhang, Guizhen ^a   Mitsuma, Terunori ^a,b  

^a Fourth Department of Medicine   (Japan)

^b Institutes for Med Science of Aging   (Japan)

^c AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

apoptosis; bcl 2; Fas antigen; immunostaining; myopathy

Indexed keywords

FAS ANTIGEN; MONOCLONAL ANTIBODY;

ANTIBODY DETECTION; APOPTOSIS; ARTICLE; BECKER MUSCULAR DYSTROPHY; DERMATOMYOSITIS; DUCHENNE MUSCULAR DYSTROPHY; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MITOCHONDRIAL MYOPATHY; MUSCLE BIOPSY;

APOPTOSIS; BLOTTING, WESTERN; HUMANS; IMMUNOENZYME TECHNIQUES; MUSCLE, SKELETAL; MUSCULAR DISEASES; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0029846707     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Tsujimoto Y, Cossman J, Jaffe E, et al : Involvement of the bcl-2 gene in human follicular lymphoma. Science 228: 1440-1443, 1985
2. Yonehara S, Ishii A, Yonehara M : A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169 : 1747-1756, 1989
3. Hockenbery D, Nunez G, Milliman C, et al : Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334-336, 1990
4. Tsujimoto Y, Croce CM : Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 83 : 5214-5218, 1986
5. Krajewski S, Tanaka S, Takayama S, et al : Investigation of the subcellular distribution of the bcl-2 oncoprotein : residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 53 : 4701-4714, 1993
6. Akao Y, Otsuki Y, Kataoka S, et al : Multiple subcellular localizaiton of bcl-2 : detection in nuclear outer membrane, endoplasmic reticulum membrane, and mitochondrial membranes. Cancer Res 54 : 2468-2471, 1994
7. Hockenbery DM, Zutter M, Hickey W, et al : BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88 : 6961-6965, 1991
8. Pezzella F, Tse AGD, Cordell JL, et al : Expression of the bcl-2 oncogene protein is not specific for the 14 ; 18 chromosomal translocation. Am J Pathol 137 : 225-232, 1990
9. Ecob-Prince M, Hill M, Brown W : Immunocytochemical demonstration of myosin heavy chain expression in human muscle. J Nurol Sci 91: 71-78, 1989
10. Davis CE, Harris JB, Nicholson LVB : Myosin isoform transitions and physiological properties of regenerated and re-innervated soleus muscles of the rat. Neuromusc Dis 1 : 411-421, 1991
11. Yamada H, Nakagawa M, Higuchi I, et al : Type II muscle fibers are stained by anti-Fas antibody. J Neurol Sci 134 : 115-118, 1995
12. Dalakas MC : Polymyositis, dermatomyositis, and inclusion-body myositis. N Eng J Med 325 : 1487-1498, 1991
13. Mizusawa H, Kurisaki H, Takatsu M, et al : Rimmed vacuolar distal myopathy. An ultrastructural study. J Neurol 234 : 137-145, 1987
14. Dubowitz V, Sewry CA, Fitzsimons RB, et al : Myotonic dystrophy. In Muscle biopsy. A practical approach. 2nd ed, ed by Dubowitz V, Sewry CA, Fitzsimons RB, et al. Baillière Tindall, London, 1985, pp 380-395